Lung cancer and immunotherapy with PD-1/PD-L1 inhibitors: what is the current scenario?

Interview with Professor Filippo De Marinis, Director of the Thoracic Oncology Division, European Institute of Oncology, Milan Subscribe to the YouTube channel http://j.mp/PharmaStarTV Or subscribe to the newsletter http://j.mp/PharmaStarNews PharmaStar is an online newspaper entirely dedicated to the world of pharmaceuticals and registered with the Court of Milan. Visit the website http://www.pharmastar.it/ Follow us on Twitter   / pharmastar   Follow us on Facebook   / pharmastarnews